ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,426Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 134

$680K Total Retail Price of All Prescriptions

Rank: 15 out of 134

656 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 656 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 656 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,687 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 1,095 999 1 1
SIMVASTATIN 761 702 2 2
OMEPRAZOLE 679 588 3 3
LISINOPRIL 575 490 4 4
AMLODIPINE BESYLATE 482 447 5 6
FUROSEMIDE 394 360 6 7
METFORMIN HCL 341 277 7 9
POTASSIUM CHLORIDE 332 308 8 10
WARFARIN SODIUM 294 269 9 8
HYDROCHLOROTHIAZIDE 281 250 10 13
GABAPENTIN 278 263 11 12
METOPROLOL TARTRATE 276 266 12 17
MELOXICAM 276 211 12 35
ALENDRONATE SODIUM 274 270 14 21
HYDROCODONE-ACETAMINOPHEN 255 223 S3 15 5
CITALOPRAM HBR 223 209 16 14
ATENOLOL 222 206 17 19
LOSARTAN POTASSIUM 178 164 18 11
SERTRALINE HCL 162 140 19 24
TRAMADOL HCL 153 128 20 22
LOSARTAN-HYDROCHLOROTHIAZIDE 152 152 21 50
ZOLPIDEM TARTRATE 150 139 22 15
GEMFIBROZIL 150 143 22 87
PAROXETINE HCL 137 128 24 46
GLIMEPIRIDE 135 104 25 36
PRAVASTATIN SODIUM 121 112 26 20
ESTRADIOL 116 110 R 27 66
ATORVASTATIN CALCIUM 114 89 28 18
VENLAFAXINE HCL ER 107 79 29 61
CARVEDILOL 106 99 30 27
CLONIDINE HCL 103 87 31 60
DONEPEZIL HCL 102 102 32 30
OXYBUTYNIN CHLORIDE 102 73 32 120
RANITIDINE HCL 99 83 34 48
FLUOXETINE HCL 99 82 34 42
OXYBUTYNIN CHLORIDE ER 96 82 36 106
FLUTICASONE PROPIONATE 94 87 37 34
TRAZODONE HCL 94 64 37 23
DIGOXIN 93 93 39 31
JANUVIA 93 90 39 77
MIRTAZAPINE 93 65 39 44
PREMARIN 92 78 R 42 84
METOPROLOL SUCCINATE 89 88 43 16
VERAPAMIL ER 84 83 44 131
LOVASTATIN 80 76 45 33
AGGRENOX 78 78 46 122
CIPROFLOXACIN HCL 78 71 46 59
LANTUS 77 75 48 32
NEXIUM 77 53 48 54
TRIAMTERENE-HCTZ 76 61 50 40
ROPINIROLE HCL 75 60 51 63
ALLOPURINOL 70 70 52 25
CYMBALTA 69 52 53 37
METFORMIN HCL ER 64 52 54 43
IBUPROFEN 63 53 55 174
POLYETHYLENE GLYCOL 3350 62 33 56 58
CELEBREX 62 62 56 111
GLIPIZIDE ER 60 60 58 131
BENAZEPRIL HCL 60 60 58 89
ACTOS 57 47 60 81
FAMOTIDINE 57 30 60 137
INSULIN SYRINGE 56 47 62 104
ADVAIR DISKUS 54 41 63 38
METOCLOPRAMIDE HCL 52 40 64 98
SPIRIVA 52 52 64 47
PREDNISONE 50 48 66 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.